C10orf113 inhibitors encompass a variety of chemical compounds that exert their inhibitory effects through distinct biochemical pathways, ultimately leading to a decrease in the functional activity of C10orf113. For instance, some of these chemicals exert their effects by interfering with the protein's translational control mechanisms. This is achieved by binding to and inhibiting key proteins that are crucial for the translation of C10orf113, resulting in diminished synthesis and subsequent activity of this protein. Others target the chromatin structure, altering DNA accessibility and the transcriptional landscape, which can suppress the expression of C10orf113. Additionally, a subset of these inhibitors modulates various kinase signaling pathways, potentially inducing a reduction in the phosphorylation state of C10orf113, which is critical for its activity. Inhibition of these pathways would lead to a cascade of events that culminate in the downregulation of C10orf113 function.
Furthermore, C10orf113 activity is presumed to be influenced by its position within several signaling cascades, including those regulated by growth factors and energy availability. Certain inhibitors act by obstructing tyrosine kinase receptors, which may cause a downstream effect on the protein if it is part of such growth factor signaling pathways. Moreover, the availability of cellular energy is a fundamental requirement for numerous biological processes, and by inhibiting the glycolytic pathway, some chemicals can indirectly lead to a reduction in C10orf113 activity, assuming it is an energy-dependent protein. Other inhibitors directly target kinases involved in cell cycle regulation, which could affect the stability and activity of C10orf113 through modifications in cell cycle dynamics.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Binds to FKBP12 and the complex inhibits mTOR, which is potentially involved in the translational control of C10orf113. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylase leading to altered chromatin structure and reduced C10orf113 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, downregulating Akt signaling and reducing C10orf113 activity given it is downstream of this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK1, which may lead to decreased activity of ERK, affecting C10orf113 given it is regulated by ERK. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, altering the phosphorylation state and activity of C10orf113 given it is a substrate. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, affecting the Akt pathway and C10orf113 activity given it is downstream of PI3K/Akt. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, affecting C10orf113 activity given it is involved in a JNK-dependent signaling pathway. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Inhibits EGFR tyrosine kinase, affecting C10orf113 given it is downstream of EGFR signaling. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Inhibits glycolysis, decreasing the energy supply necessary for C10orf113's activity if it is energy-dependent. | ||||||
MLN8237 | 1028486-01-2 | sc-394162 | 5 mg | $220.00 | ||
Inhibits Aurora A kinase, affecting C10orf113 activity given it is involved in the cell cycle regulation. | ||||||